Skip to content
  • Saturday, 15 August 2026
  • 1:31 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Pioneering Mass Spectrometry Innovator Albert Heck Honored with John B. Fenn Distinguished Contribution Award at ASMS 2026
Biotech & Genetic Research

Pioneering Mass Spectrometry Innovator Albert Heck Honored with John B. Fenn Distinguished Contribution Award at ASMS 2026

Jia Lissa Jul 4, 2026 0

Albert Heck, Professor of Biomolecular Mass Spectrometry (MS) and Proteomics at Utrecht University in The Netherlands, a visionary whose groundbreaking…

Read More
Biotech & Genetic Research

Professor Albert Heck Honored with John B. Fenn Award for Transformative Contributions to Biomolecular Mass Spectrometry

Jia Lissa Jun 26, 2026 0

The scientific community at the American Society for Mass Spectrometry (ASMS) 2026 conference, held from May 31 to June 4…

Read More
How Clinical Laboratories Can Prepare for Crisis Events Before They HappenImmunai’s Digital "Plumbing" Secures Third Expansion with AstraZeneca, Deepening AI Integration Across Clinical PipelineBreakthrough Research Uncovers Blood Metabolite Signatures for Earlier Gallbladder Cancer Detection, Promising Non-Invasive DiagnosticsMIT Engineers Reveal How Muscle Exercise Directly Stimulates Nerve Growth Through Biochemical and Physical Mechanisms
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ